Difference between revisions of "Test"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[unchecked revision][unchecked revision]
Line 12: Line 12:
 
*[[Systemic Mastocytosis]]
 
*[[Systemic Mastocytosis]]
 
*[[Mast Cell Sarcoma]]
 
*[[Mast Cell Sarcoma]]
 +
 +
== Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 ==
 +
*[[Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement]]
 +
*[[Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement]]
 +
*[[Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement]]
 +
*[[Myeloid/Lymphoid Neoplasms with PCM1-JAK2]]
  
 
== Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) ==
 
== Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) ==
Line 19: Line 25:
 
*[[Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)|MDS/MPN with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)]]
 
*[[Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)|MDS/MPN with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)]]
 
*[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]]
 
*[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]]
 +
 +
== Myelodysplastic Syndromes (MDS) ==
 +
*[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]]
 +
*[[Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)|MDS with Ring Sideroblasts (MDS-RS)]]
 +
*[[Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia|MDS with Ring Sideroblasts and Multilineage Dysplasia]]
 +
*[[Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia|MDS with Multilineage Dysplasia]]
 +
*[[Myelodysplastic Syndrome (MDS) with Excess Blasts|MDS with Excess Blasts]]
 +
*[[Myelodysplastic Syndrome (MDS) with Isolated del(5q)|MSD with Isolated del(5q)]]
 +
*[[Myelodysplastic Syndrome (MDS), Unclassifiable|MDS, Unclassifiable]]
 +
*[[Refractory Cytopenia of Childhood]]
 +
 +
== Myeloid Neoplasms with Germline Predisposition]] ==
 +
 +
  - [[Acute Myeloid Leukaemia with Germline CEBPA Mutation]]
 +
  - [[Myeloid Neoplasms with Germline DDX41 Mutation]]
 +
  - [[Myeloid Neoplasms with Germline RUNX1 Mutation]]
 +
  - [[Myeloid Neoplasms with Germline ANKRD26 Mutation]]
 +
  - [[Myeloid Neoplasms with Germline ETV6 Mutation]]
 +
  - [[Myeloid Neoplasms with Germline GATA2 Mutation]]
  
 
== Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms ==
 
== Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms ==
Line 70: Line 95:
 
   - [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]]
 
   - [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]]
  
−
*[[Myeloid Neoplasms with Germline Predisposition]]
 
  
−
  - [[Acute Myeloid Leukaemia with Germline CEBPA Mutation]]
 
−
  - [[Myeloid Neoplasms with Germline DDX41 Mutation]]
 
−
  - [[Myeloid Neoplasms with Germline RUNX1 Mutation]]
 
−
  - [[Myeloid Neoplasms with Germline ANKRD26 Mutation]]
 
−
  - [[Myeloid Neoplasms with Germline ETV6 Mutation]]
 
−
  - [[Myeloid Neoplasms with Germline GATA2 Mutation]]
 
  
−
== Myelodysplastic Syndromes (MDS) ==
 
−
*[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]]
 
−
*[[Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)|MDS with Ring Sideroblasts (MDS-RS)]]
 
−
*[[Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia|MDS with Ring Sideroblasts and Multilineage Dysplasia]]
 
−
*[[Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia|MDS with Multilineage Dysplasia]]
 
−
*[[Myelodysplastic Syndrome (MDS) with Excess Blasts|MDS with Excess Blasts]]
 
−
*[[Myelodysplastic Syndrome (MDS) with Isolated del(5q)|MSD with Isolated del(5q)]]
 
−
*[[Myelodysplastic Syndrome (MDS), Unclassifiable|MDS, Unclassifiable]]
 
−
*[[Refractory Cytopenia of Childhood]]
 
  
 
== Precursor Lymphoid Neoplasms ==
 
== Precursor Lymphoid Neoplasms ==

Revision as of 17:37, 20 February 2021

Myeloproliferative Neoplasms (MPN)

Mastocytosis

Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2

Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

Myelodysplastic Syndromes (MDS)

Myeloid Neoplasms with Germline Predisposition]]

  - Acute Myeloid Leukaemia with Germline CEBPA Mutation
  - Myeloid Neoplasms with Germline DDX41 Mutation
  - Myeloid Neoplasms with Germline RUNX1 Mutation
  - Myeloid Neoplasms with Germline ANKRD26 Mutation
  - Myeloid Neoplasms with Germline ETV6 Mutation
  - Myeloid Neoplasms with Germline GATA2 Mutation

Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms

  - AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1
  - AML with with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11
  - Acute Promyelocytic Leukemia (APL) with PML-RARA
  - AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3
  - AML with t(6;9)(p23;q34.1); DEK-NUP214
  - AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM
  - AML Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1
  - AML with BCR-ABL1
  - AML with Mutated NPM1
  - AML with Biallelic Mutations of CEBPA
  - AML with Mutated RUNX1

  - AML with Minimal Differentiation
  - AML without Maturation
  - AML with Maturation
  - Acute Myelomonocytic Leukemia
  - Acute Monoblastic and Monocytic Leukemia
  - Pure Erythroid Leukemia
  - Acute Megakaryoblastic Leukemia (AMKL)
  - Acute Basophilic Leukemia
  - Acute Panmyelosis with Myelofibrosis

  - Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome
  - Myeloid Leukemia Associated with Down Syndrome

  - Acute Undifferentiated Leukemia
  - Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1
  - Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged
  - Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified
  - Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified
  - Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types
  - Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)



Precursor Lymphoid Neoplasms

  - B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1
  - B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged
  - B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1
  - B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy
  - B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy
  - B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3
  - B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1
  - B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like
  - B-Lymphoblastic Leukemia/Lymphoma with iAMP21
  - B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified

  - Early T-Cell Precursor Lymphoblastic Leukemia
  - NK-Lymphoblastic Leukemia/Lymphoma

Mature B-Cell Neoplasms

  - Monoclonal B-cell Lymphocytosis

  - Splenic Diffuse Red Pulp Small B-cell Lymphoma
  - Hairy Cell Leukemia Variant

  - Waldenstrom Macroglobulinemia

  - Mu Heavy Chain Disease
  - Gamma Heavy Chain Disease
  - Alpha Heavy Chain Disease

  - Non-IgM Monoclonal Gammopathy of Undetermined Significance
  - Plasma Cell Myeloma
  - Plasma Cell Myeloma Variants
  - Plasmacytoma
  - Monoclonal Immunoglobulin Deposition Diseases
        - Primary Amyloidosis
        - Light Chain and Heavy Chain Deposition Disease
  - Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome
        - POEMS Syndrome
        - TEMPI Syndrome

  - Paediatric Nodal Marginal Zone Lymphoma

  - Testicular Follicular Lymphoma
  - In Situ Follicular Neoplasia
  - Duodenal-Type Follicular Lymphoma

  - Leukemic Non-Nodal Mantle Cell Lymphoma
  - In Situ Mantle Cell Neoplasia

  - Fibrin-Associated Diffuse Large B-cell Lymphoma

  - Multicentric Castleman Disease
  - HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)
  - HHV8-Positive Germinotropic Lymphoproliferative Disorder

  - High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements
  - High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)

Mature T- and NK-cell Neoplasms

  - Systemic EBV-Positive T-cell Lymphoma of Childhood
  - Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form
  - Hydroa Vacciniforme-Like Lymphoproliferative Disorder
  - Severe Mosquito Bite Allergy

  - Enteropathy-Associated T-cell Lymphoma
  - Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
  - Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)
  - Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract

  - Lymphomatoid Papulosis
  - Primary Cutaneous Anaplastic Large Cell Lymphoma

  - Primary Cutaneous Gamma Delta T-cell Lymphoma
  - Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma
  - Primary Cutaneous Acral CD8+ T-cell Lymphoma
  - Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder

  - Angioimmunoblastic T-cell Lymphoma
  - Follicular T-cell Lymphoma
  - Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype



Dan

40 months ago
Score 0++
just a test comment

Permalink | Reply

Dan

40 months ago
Score 0++
just a reply
Permalink
Add your comment
Compendium of Cancer Genome Aberrations welcomes all comments. If you do not want to be anonymous, register or log in. It is free.

Retrieved from "https://ccga.io/index.php?title=Test&oldid=9680"